DOCN vs GEN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 20, 2026

DOCN

41.6
AI Score
VS
DOCN Wins

GEN

33.5
AI Score

Investment Advisor Scores

DOCN

42score
Recommendation
HOLD

GEN

34score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCN GEN Winner
Forward P/E 67.1141 10.5042 GEN
PEG Ratio 1.5379 1.5441 DOCN
Revenue Growth 28.6% 6.3% DOCN
Earnings Growth -24.5% 64.0% GEN
Tradestie Score 41.6/100 33.5/100 DOCN
Profit Margin 23.3% 20.7% DOCN
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL DOCN

Relative Price Performance (Last 90 Days)

DOCN 1M: +28.4% · 3M: +7.4% GEN 1M: -25.9% · 3M: -16.6%

Current Technical Phase

DOCN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.9 · Price: $139.80

GEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 29

RSI (14): 29.1 · Price: $22.25

Fundamentals Snapshot

Metric DOCN GEN
Market Cap — —
Forward P/E 75.9 7.8
Trailing P/E 60.6 12.9
Revenue (TTM) — —
Revenue Growth 0.3% 0.1%
Gross Margin 0.6% 0.8%
Operating Margin 0.1% 0.4%
EPS 2.20 1.71
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, DOCN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.